Misplaced Pages

The following pages link to Humanized antibody

• (link count
• transclusion count
• sorted list) · See help page for transcluding these entries

Showing 50 items.

• Monoclonal antibody (links | edit)
• Infliximab (links | edit)
• Basiliximab (links | edit)
• Daclizumab (links | edit)
• 1997 in science (links | edit)
• 1986 in science (links | edit)
• Trastuzumab (links | edit)
• Abciximab (links | edit)
• Rituximab (links | edit)
• Omalizumab (links | edit)
• Bevacizumab (links | edit)
• Humanised antibody (redirect page) (links | edit)
• Cetuximab (links | edit)
• Cancer immunotherapy (links | edit)
• Adalimumab (links | edit)
• Gregory Winter (links | edit)
• Natalizumab (links | edit)
• Humanized monoclonal antibody (redirect page) (links | edit)
  • Paroxysmal nocturnal hemoglobinuria (links | edit)
  • Daclizumab (links | edit)
  • Eculizumab (links | edit)
  • Bapineuzumab (links | edit)
  • Bivatuzumab mertansine (links | edit)
  • Cantuzumab mertansine (links | edit)
  • Erlizumab (links | edit)
  • Fontolizumab (links | edit)
  • Pascolizumab (links | edit)
  • Reslizumab (links | edit)
  • Rovelizumab (links | edit)
  • Ruplizumab (links | edit)
  • Talizumab (links | edit)
  • Tocilizumab (links | edit)
  • Toralizumab (links | edit)
  • Visilizumab (links | edit)
  • Felvizumab (links | edit)
  • Motavizumab (links | edit)
  • Inotuzumab ozogamicin (links | edit)
  • Lintuzumab (links | edit)
  • Matuzumab (links | edit)
  • Sibrotuzumab (links | edit)
  • Yttrium (90Y) tacatuzumab tetraxetan (links | edit)
  • Tefibazumab (links | edit)
  • Tucotuzumab celmoleukin (links | edit)
  • CD22 (links | edit)
  • Epratuzumab (links | edit)
  • Urtoxazumab (links | edit)
  • Etaracizumab (links | edit)
  • Dacetuzumab (links | edit)
  • Lebrikizumab (links | edit)
  • Bi-specific T-cell engager (links | edit)
  • Vitaxin (links | edit)
  • Romosozumab (links | edit)
  • Demcizumab (links | edit)
  • Human endogenous retrovirus-W (links | edit)
  • PDL BioPharma (links | edit)
  • Emactuzumab (links | edit)
  • Lenzilumab (links | edit)
  • Nemolizumab (links | edit)
  • Satralizumab (links | edit)
  • COVID-19 drug repurposing research (links | edit)
  • Talquetamab (links | edit)
  • Zanidatamab (links | edit)
  • Zenocutuzumab (links | edit)
  • User:Brainist/MeSH articles/redlinks (links | edit)
• Biopharmaceutical (links | edit)
• Ibritumomab tiuxetan (links | edit)
• Alemtuzumab (links | edit)
• Gemtuzumab ozogamicin (links | edit)
• Immunogenicity (links | edit)
• Theralizumab (links | edit)
• Pharmacotherapy (links | edit)
• Efalizumab (links | edit)
• Nomenclature of monoclonal antibodies (links | edit)
• Ranibizumab (links | edit)
• Certolizumab pegol (links | edit)
• Tositumomab (links | edit)
• Palivizumab (links | edit)
• Eculizumab (links | edit)
• Monoclonal antibody therapy (links | edit)
• Panitumumab (links | edit)
• Edrecolomab (links | edit)
• Apolizumab (links | edit)
• List of therapeutic monoclonal antibodies (links | edit)
• Bapineuzumab (links | edit)
• Ecromeximab (links | edit)
• Abagovomab (links | edit)
• Ustekinumab (links | edit)
• Pertuzumab (links | edit)
• Oregovomab (links | edit)
• Technetium (99mTc) fanolesomab (links | edit)
• Besilesomab (links | edit)
• Lemalesomab (links | edit)
• Technetium (99mTc) sulesomab (links | edit)
• Denosumab (links | edit)
• Gavilimomab (links | edit)
• Afelimomab (links | edit)